Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harrison Kwei Tsai, M.D.

Concepts (182)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Harrison Tsai's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Harrison Tsai has written about over time.
Cyclin D1, 1 publications between 2015 and 2015, average publication date August 2015. Carcinoma, Small Cell, 2 publications between 2015 and 2019, average publication date July 2017. High-Throughput Nucleotide Sequencing, 4 publications between 2014 and 2021, average publication date March 2018. Prostatic Neoplasms, 13 publications between 2015 and 2022, average publication date October 2018. fms-Like Tyrosine Kinase 3, 3 publications between 2015 and 2023, average publication date January 2020. Small Cell Lung Carcinoma, 1 publications between 2020 and 2020, average publication date March 2020. Carcinoma, Neuroendocrine, 5 publications between 2017 and 2022, average publication date March 2020. Diagnosis, Computer-Assisted, 1 publications between 2020 and 2020, average publication date June 2020. Medical Informatics, 1 publications between 2020 and 2020, average publication date June 2020. Tandem Repeat Sequences, 2 publications between 2020 and 2021, average publication date January 2021. Repressor Proteins, 3 publications between 2020 and 2021, average publication date February 2021. Leukemia, Myeloid, Acute, 6 publications between 2015 and 2023, average publication date June 2021. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 3 publications between 2020 and 2023, average publication date January 2022. Histone-Lysine N-Methyltransferase, 1 publications between 2022 and 2022, average publication date July 2022. Myeloid-Lymphoid Leukemia Protein, 1 publications between 2022 and 2022, average publication date July 2022. Myelodysplastic Syndromes, 2 publications between 2022 and 2023, average publication date February 2023. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 1 publications between 2023 and 2023, average publication date July 2023. Hematologic Neoplasms, 2 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Tsai's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (182)
Explore
_
Co-Authors (101)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.